Question 1

How does Oxtongue Bugloss work as an expectorant and demulcent?

Accepted Answer

Oxtongue Bugloss contains significant mucilage content that forms a soothing gel-like layer when mixed with water, providing demulcent effects that coat and protect irritated mucous membranes in the respiratory tract. This coating action helps relieve inflammation and soothe catarrh. The mucilage also promotes expectoration by increasing mucus production and facilitating clearance from airways. Tannins contribute mild astringent properties, while flavonoids provide additional anti-inflammatory effects. Evidence level: C (traditional use supported by pharmacological understanding of constituents).

Question 2

Does Oxtongue Bugloss interact with any medications?

Accepted Answer

Oxtongue Bugloss contains pyrrolizidine alkaloids (PAs), which are metabolized by the liver into toxic compounds. This herb should not be combined with medications that stress liver function, including acetaminophen, statins, antifungal medications, or alcohol. PAs may potentially interact with drugs metabolized by cytochrome P450 enzymes. Avoid combining with other hepatotoxic herbs such as comfrey, coltsfoot, or borage. No specific clinical drug interaction studies exist (Evidence level: D), but the PA content warrants significant caution with any liver-affecting substances.

Question 3

What is the recommended dosage for Oxtongue Bugloss tea?

Accepted Answer

The traditional adult dosage for Oxtongue Bugloss is 1-2 grams of dried leaves prepared as an infusion, taken up to three times daily. For topical application, a poultice can be prepared from fresh or dried herb applied to affected skin areas. Due to pyrrolizidine alkaloid content, internal use should be strictly limited to 2-4 weeks maximum. This dosing is based on traditional Mediterranean and Middle Eastern folk medicine (Evidence level: C) rather than controlled clinical trials. Consult a qualified medical herbalist before use.

Question 4

Is Oxtongue Bugloss safe during pregnancy and breastfeeding?

Accepted Answer

No, Oxtongue Bugloss is contraindicated during pregnancy and breastfeeding. The herb contains pyrrolizidine alkaloids (PAs), which are confirmed hepatotoxins with demonstrated teratogenic effects that can harm fetal development. These compounds cross the placenta and pass into breast milk, posing serious risks to nursing infants. Children should also not be given this herb. Women who are pregnant, breastfeeding, or planning pregnancy must avoid all PA-containing herbs entirely. Evidence level: C based on constituent toxicity data and established safety concerns.

Question 5

What are the side effects of Oxtongue Bugloss?

Accepted Answer

The primary safety concern with Oxtongue Bugloss is hepatotoxicity caused by its pyrrolizidine alkaloid content. Prolonged or excessive use can lead to hepatic veno-occlusive disease, a serious and potentially fatal liver condition. Symptoms may include abdominal pain, jaundice, fatigue, and liver enlargement. The herb is contraindicated for individuals with pre-existing liver disease. Traditional use suggests tolerance at recommended doses for short durations, but due to PA content, many herbal authorities recommend avoiding internal use entirely in favor of safer alternatives. Evidence level: C.

Oxtongue Bugloss

Sources et citations

Calculer une dose sûre de Oxtongue Bugloss

Questions fréquentes

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Interactions médicamenteuses

Synthèse des preuves

Sources PubMed

Sources gouvernementales